AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CRISPR Therapeutics AG

$51.42 -$2.35 (-4.37%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$54.26
Day Range
$50.60$54.10
Year Range
$44.12$64.74
Market Cap
4.97B
AVG Volume
1.6M
Trailing/Forward PE
-10.8/-
PEG ratio
0.36
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CRSP Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q213.39M
26 Q14.1M
25 Q43.51M
25 Q337.65M
25 Q237.36M
25 Q136.98M
24 Q436.62M
24 Q3201.62M
24 Q2201.02M
24 Q1270.5M
Net Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CRSP Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-451.14M
26 Q1-568.53M
25 Q4-581.6M
25 Q3-488.3M
25 Q2-467.8M
25 Q1-385.66M
24 Q4-366.25M
24 Q3-239.59M
24 Q2-265.8M
24 Q1-217.14M
Operating Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CRSP Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-531.87M
26 Q1-550.14M
25 Q4-568.32M
25 Q3-478.14M
25 Q2-456.21M
25 Q1-474.4M
24 Q4-466.56M
24 Q3-332.39M
24 Q2-354.68M
24 Q1-298.64M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: CRSP

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 9 Nov 2026.

CRISPR Therapeutics AG
CRSP
Stockpicker

Video analysis: CRSP

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CRSP

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.